Does adrenal androgen production become the main source of downstream testosterone and estrogen after menopause?

During menopause, the depletion of ovarian follicles triggers a profound shift in the female endocrine landscape. Direct ovarian secretion of active estrogens declines sharply, transitioning the body from systemic, gland-derived hormone delivery to localized, tissue-specific synthesis.

Ovarian decline and endocrine transition

• Follicular depletion leads to a near-complete cessation of direct ovarian estrogen secretion.
• Although the postmenopausal ovary may retain some capacity to secrete weak androgens under luteinizing hormone stimulation, its contribution to direct circulating estrogen is minimal.

Intracrine conversion mechanisms

• Following the decline in ovarian function, adrenal-derived dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S) become the dominant precursor pool for sex steroid synthesis.
• Peripheral target tissues—including adipose tissue, bone, breast, and skin—take up these inactive circulating adrenal precursors to synthesize active testosterone and estrogens locally.
• This localized synthesis relies on cell-specific intracrine enzymes, including steroid sulfatase, 3β-hydroxysteroid dehydrogenase (3β-HSD), 17β-hydroxysteroid dehydrogenase (17β-HSD), and aromatase. This pathway directly generates estrone, estradiol, and testosterone within target cells, allowing essential hormonal actions to persist even when circulating serum levels are extremely low.

Bottom line

• Following the postmenopausal decline in ovarian function, adrenal DHEA and DHEA-S serve as the primary, essential precursor pool that sustains localized estrogen and testosterone availability via peripheral tissue intracrine pathways.